FDA Approves Eli Lilly's Zepbound for Obesity and Sleep Apnea Treatment | Groundbreaking Dual-Use Drug

10 hrs ago 2

The FDA has recently announced a groundbreaking expansion in the approval of Eli Lilly's obesity drug, Zepbound, now also sanctioned for treating moderate to severe obstructive sleep apnea in individuals grappling with obesity.

View Entire Post

Read Entire Article